The purpose of this legislation, known as the Fair Prescription Drug Prices for Americans Act, is to lower the retail prices of certain prescription drugs and biological products in the United States. It aims to ensure that these prices do not exceed the average prices for the same products in several other countries, specifically Canada, France, Germany, Italy, Japan, and the United Kingdom. The key provisions of the law include a cap on the retail list price of prescription drugs and biological products.